180
Participants
Start Date
December 5, 2008
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Activated T lymphocyte(Immuncell-LC)
"Efficacy/Effects: Removal of minimal residual cancer after removal of brain tumors and relapse prevention~Method of administration and quantity: Test Drug: Per 60kg of average adult body weight, administer 100mg that contains 109\~2x1010 lymphocytes for one hour intravenously. (Duration of administration can be controlled based on patient conditions)"
Hanyang University Guri Hospital, Guri-si
Gyunghee University Medical Center, Seoul
Konkuk University, Seoul
Korea University Anam Hospital, Seoul
Samsung Seoul Medical Center, Seoul
Seoul Asan Medical Center, Seoul
Yeonsei University Medical Center, Seoul
Lead Sponsor
GC Cell Corporation
INDUSTRY